Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion type Assertion NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_head.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion description "[In conclusion, our study has revealed a new mode of PI3K alteration in primary endometrial tumors and warrants future studies to determine whether PIK3R1 mutations correlate with clinical outcome to targeted therapies directed against the PI3K pathway in EEC and NEEC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_provenance.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion evidence source_evidence_literature NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_provenance.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion SIO_000772 21478295 NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_provenance.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion wasDerivedFrom befree-2016 NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_provenance.
- NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_assertion wasGeneratedBy ECO_0000203 NP885689.RADxBYfaM7oKY6MK1IhRR8YD8D6CEtVbJSKSHLgIaabh4130_provenance.